Ivabradine | Circulation - AHA/ASA Journals
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.115.018094
WebMay 24, 2016 · Ivabradine is approved to reduce hospitalizations for patients with symptomatic heart failure, reduced ejection fraction, and persistently elevated heart rate despite otherwise maximal medical therapy. However, the eligible patient population is a small fraction of those with heart failure overall.
DA: 35 PA: 33 MOZ Rank: 90